Sirt1 hyperexpression in SHR heart related to left ventricular hypertrophy

Canadian Journal of Physiology and Pharmacology
Ling LiDing-Feng Su

Abstract

Sirt1 is a human homologue of the silent information regulator factor 2 (Sir2) and has an NAD+-dependent histone deacetylase activity. This protein is reported to have a pathogenetic role in muscle differentiation, diabetic nephropathy, and heart failure. In this study, we investigated the expression of sirt1 in spontaneously hypertensive rat (SHR) to obtain insight into the function of sirt1 in hypertensive cardiovascular hypertrophy. The gene and protein expression of sirt1 was increased in the heart in SHR compared with normotensive WKY rats. Sirt1 mRNA was not different in the aorta between SHR and WKY rats. Sirt1 mRNA expression in heart and aorta was not related to hemodynamic parameters in SHR. Hypertensive left ventricular hypertrophy was significantly and positively related to the expression of heart tissue sirt1 mRNA in SHR. Aortic hypertrophy, however, was not related to sirt1 mRNA in the aorta. The increased sirt1 protein expression was accompanied by severe cardiac hypertrophy in older SHR. These results suggest that the increase of sirt1 gene and protein expression in the heart was associated with cardiac hypertrophy.

References

Jul 31, 2003·Molecular Cell·Marcella FulcoVittorio Sartorelli
Aug 3, 2005·Journal of Human Hypertension·C Thuillez, V Richard
Nov 18, 2005·Pharmacology & Therapeutics·G Cohuet, H Struijker-Boudier
Feb 17, 2006·Current Opinion in Nephrology and Hypertension·M Eugenia Cifuentes, Patrick J Pagano
May 12, 2006·The Journal of Biological Chemistry·Ieng-Yi ChenMaha Abdellatif
Jul 18, 2006·Cardiovascular & Hematological Agents in Medicinal Chemistry·Anna M Grandi, Andrea M Maresca
Nov 4, 2006·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Peter A Meredith, Jan Ostergren
Feb 22, 2007·The Canadian Journal of Cardiology·Faye S RoutledgeUNKNOWN Canadian Hypertension Society
Apr 21, 2007·Circulation Research·Ralph R AlcendorJunichi Sadoshima
Jun 30, 2007·Clinical and Experimental Pharmacology & Physiology·Fu-Ming ShenDing-Feng Su

❮ Previous
Next ❯

Citations

May 6, 2009·Clinical and Experimental Pharmacology & Physiology·Jun-Li DuanYe-Ye Du
Dec 17, 2009·American Journal of Physiology. Heart and Circulatory Physiology·M SulaimanM Gupta
Dec 22, 2011·Future Cardiology·Zhao Zhong ChongKenneth Maiese
Mar 19, 2011·Biochemical and Biophysical Research Communications·Catherine L PassarielloClaudio Stefanelli
Feb 1, 2011·Journal of Molecular and Cellular Cardiology·Nagalingam R SundaresanMahesh P Gupta
Dec 3, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Lina Ma, Yun Li
Jul 14, 2011·Biochimica Et Biophysica Acta·Vernon W Dolinsky, Jason R B Dyck
Oct 12, 2013·European Journal of Pharmacology·Negara Tajbakhsh, Elke M Sokoya
Jul 5, 2016·Pathophysiology : the Official Journal of the International Society for Pathophysiology·David N WilsonTom L Broderick
Sep 20, 2018·Clinical and Experimental Hypertension : CHE·Hakan DumanMustafa Çetin
Nov 13, 2013·Circulation·Yang YangDinghua Yi
Dec 24, 2019·Frontiers in Pharmacology·Zhiling QiuYuanhui Hu
May 27, 2017·Oxidative Medicine and Cellular Longevity·Weijin ZhangZhongqing Chen
Nov 27, 2020·Biomolecules·Valeria ContiAmelia Filippelli
Apr 20, 2021·Frontiers in Cell and Developmental Biology·Runze WangMingming Zhang
Jul 17, 2021·American Journal of Physiology. Heart and Circulatory Physiology·Ekhtear HossainMadhu B Anand-Srivastava
Jun 11, 2014·Journal of Biomedical Science·Tse-Min LuChiao-Po Hsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.